Holen Sie sich die Stockscreener-App
6.41
0.63%
0.04
Schlusskurs vom Vortag:
$6.37
Offen:
$6.42
24-Stunden-Volumen:
349.02K
Relative Volume:
1.08
Marktkapitalisierung:
$173.55M
Einnahmen:
$348.67M
Nettoeinkommen (Verlust:
$-22.75M
KGV:
-6.9948
EPS:
-0.9164
Netto-Cashflow:
$-21.60M
1W Leistung:
+1.75%
1M Leistung:
+1.75%
6M Leistung:
-6.15%
1J Leistung:
-2.88%
1-Tages-Spanne:
$6.33
$6.47
1-Wochen-Bereich:
$6.27
$6.585
52-Wochen-Spanne:
$5.3401
$9.13
Inogen Inc Stock (INGN) Company Profile
Firmenname
Inogen Inc
Sektor
Branche
Telefon
805-562-0500
Adresse
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.41 | 173.55M | 348.67M | -22.75M | -21.60M | -0.9164 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | B. Riley Securities | Buy |
| 2025-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-02-15 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-07-14 | Herabstufung | Needham | Buy → Hold |
| 2023-01-17 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | Hochstufung | Needham | Hold → Buy |
| 2021-11-02 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | Herabstufung | Needham | Buy → Hold |
| 2020-05-06 | Bestätigt | Needham | Buy |
| 2019-11-06 | Hochstufung | Needham | Hold → Buy |
| 2019-09-13 | Bestätigt | Piper Jaffray | Overweight |
| 2019-08-08 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | Herabstufung | Stifel | Buy → Hold |
| 2019-08-07 | Herabstufung | Needham | Buy → Hold |
| 2019-06-28 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-05-08 | Bestätigt | Needham | Strong Buy |
| 2019-02-27 | Bestätigt | Needham | Strong Buy |
| 2018-11-20 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-11-07 | Bestätigt | Needham | Buy |
| 2018-09-10 | Herabstufung | Needham | Strong Buy → Buy |
| 2018-08-22 | Fortgesetzt | Stifel | Buy |
| 2018-08-08 | Bestätigt | Needham | Strong Buy |
| 2018-06-06 | Eingeleitet | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | Bestätigt | Needham | Strong Buy |
| 2018-02-28 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Inogen Inc Aktie (INGN) Neueste Nachrichten
Precision Trading with Inogen Inc (INGN) Risk Zones - Stock Traders Daily
Inogen Inc (INGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inogen Inc (INGN) Institutional Confidence - TradingKey
Inogen Inc (INGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Inogen Inc (INGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Inogen Inc (INGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inogen Inc (INGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inogen Inc (INGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inogen Inc (INGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inogen Inc (INGN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inogen Inc Stock (US45780L1044): Valuation metrics under the microscope - AD HOC NEWS
INGN SEC FilingsInogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Here's why you should retain Inogen stock in your portfolio for now - MSN
Former ZimVie CEO Joins Inogen’s Board of Directors - Medical Product Outsourcing
Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan and Stock Option Agreement Details 57 - Minichart
Inogen Shareholders Approve Expanded Equity Incentive Plan - TipRanks
Inogen (NASDAQ: INGN) holders back equity plan but keep staggered board - Stock Titan
Inogen (INGN) director awarded 28,081 RSUs, boosting share holdings - Stock Titan
Inogen (INGN) director Jamali Vafa receives 28,081-share RSU grant - Stock Titan
Inogen Inc (INGN) awards director Glenn Boehnlein 28,081 stock units - Stock Titan
Inogen (NASDAQ: INGN) director granted 28,081 restricted stock units in equity award - Stock Titan
Inogen (NASDAQ: INGN) director awarded 28,081 restricted stock units - Stock Titan
Inogen (INGN) director receives 28,081-share restricted stock unit grant - Stock Titan
Jamali Vafa (INGN) files Form 3 disclosing 15,000 Inogen common shares - Stock Titan
· Analyst Forecast - MLQ.ai
Inogen (INGN) Advances as Trading Activity Picks Up, Testing ResistanceHot Stock Picks - newsline.com
Inogen Inc stock (US45780L1044): Nasdaq-listed oxygen therapy specialist sees active trading ahead o - AD HOC NEWS
Pulmonary Devices Market Competitive Analysis to 2031 | Inogen Inc., Invacare Corporation, O2 Concepts etc. - openPR.com
Inogen appoints Vafa Jamali to board of directors - Investing.com
Inogen Welcomes Three New Executive Team Members - Medical Product Outsourcing
Freedom Broker initiates Inogen stock coverage with buy rating on respiratory platform growth - Investing.com
INGN Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesAnalyst Earnings Estimate - newsline.com
Inogen Inc EVP Jennifer Yi Boyer sells $70,313 of common stock - Investing.com Canada
Inogen Inc EVP Jennifer Yi Boyer sells $70,313 of common stock By Investing.com - Investing.com South Africa
Inogen (INGN) HR chief sells 10,770 shares under Rule 10b5-1 plan - Stock Titan
Inogen Inc stock (US45780L1044): shares ease after May volatility as investors await next catalysts - AD HOC NEWS
[144] Inogen Inc SEC Filing - Stock Titan
INGN Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Stock DeclinesEarnings Surprise Report - The Legal Advocate
Inogen Inc (INGN) Holds Near Support as Shares Drift LowerInsider Selling Alerts - newsline.com
Inogen (INGN) Sees Mild Uptick, Consolidates Near Key ResistanceEarnings Breakout Stocks - newsline.com
Inogen Inc Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesEarnings Surprise Stocks - newsline.com
Q3 2025 Inogen Inc Earnings Call Transcript - GuruFocus
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now - Yahoo Finance
Inogen Earnings Call: International Strength Amid U.S. Strain - TipRanks
What Inogen (INGN)'s -1.25% Decline Means for Investors 2026-05-18Wave Equality - The Legal Advocate
Inogen stock (US45780L1044): respiratory player in focus after Q1 2026 update and restructuring plan - AD HOC NEWS
Inogen, IncCommon Stock (NQ: INGN - The Chronicle-Journal
Inogen (INGN) Q1 2026 Results Miss Estimates — EPS $-0.30 vs $-0.29Earnings Decline Risk - The Legal Advocate
Number of shareholders of Inogen, Inc. – FWB:6IO - TradingView
Inogen Q1 2026 slides: revenue beats amid profitability pressure By Investing.com - Investing.com Nigeria
Inogen Q1 2026 slides: revenue beats amid profitability pressure - Investing.com
Finanzdaten der Inogen Inc-Aktie (INGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):